Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1983-06-29
1985-12-10
Rosen, Sam
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 23, A61K 3702
Patent
active
045580324
ABSTRACT:
A composition of matter which comprises a synthetic whole blood useful as a substitute for whole natural blood and a method of making the same are disclosed. The method of manufacture yields a composition of matter comprised of a two phase coacervate system. The claimed system successfully duplicates the two phase heterogeneous physico-chemical system of naturally occurring whole blood. Also disclosed is a phase of the claimed method of manufacture which produces a composition of matter, useful as a substitute for hematocrit. Also disclosed is an embodiment employing a hemoglobin component which is preferably selected from stroma free hemoglobin, synthetic liposomes containing stroma free hemoglobin, microencapsulated stroma free hemoglobin, or emulsified droplets of coacervate containing stroma free hemoglobin. It is preferred that the microencapsulated stroma free hemoglobin when employed ranges in size from 0.1 to 10 microns. Among the main ingredients of the blood substitute composition are gelatin or modified fluid gelatin and acacia.
REFERENCES:
patent: 2591133 (1952-04-01), Campbell et al.
patent: 4001401 (1977-04-01), Bonsen et al.
patent: 4002739 (1977-01-01), Turner et al.
patent: 4133874 (1979-01-01), Miller et al.
Nahas et al.--Blood Substitutes and Plasma Expanders, (1978), Pub. Alan R. Liss, N.Y., pp. 259-264.
Ricketts--The Chemist and Druggist, vol. 156, (Oct. 13, 1951), pp. 495-497.
P. Lundsgaard-Hansen, M.D. and B. Tschirren, M.D., "Modified Fluid Gelatin as a Plasma Substitute", Blood Substitutes and Plasma Expanders, (New York: Alan R. Liss, 1978), p. 227.
Information in a letter to B. H. Gold, M.D. from H. U. Frey, M.D., Director of the Blood Transfusion Service, Central Laboratory , Berne, Switzerland, Dec. 6, 1982 and Jan. 5, 1983.
Ashwood-Smith, M. S., "Polyvinyl-Pyrolidone Solutions Used in Plasma Expander Potential Carcinogens"; Lancet 1, (1971), p. 1304.
De Venute, Frank and Zegna, Angelo, "Blood Exchanger with Pyridoxilated and Polymerized Hemoglobin Solution", Surgery, Gynecology and Obstetrics, vol. 155, (Sep. 1982), pp. 342-346.
Bucala et al, "Cytoxicity of a Perfluorocarbon Blood Substitute to Macrophages in Vitro", Science, vol. 220, (May 1983), pp. 965-967.
Arthur Osol, ed., Remington's Pharmaceutical Sciences, (Easton, Pa.: Mack Publishing Co., 1975), p. 315.
J. McMullen et al, "Pectin-Gelatin Complex Coacervates", Journal of Pharmaceutical Science, vol. 71, No. 6, (Jun. 1982), pp. 628-633.
Gessner G. Hawley, ed., The Condensed Chemical Dictionary, 9th ed., (New York: Van Nostrand Reinhold Company, 1977), p. 213.
"Blood", Van Nostrand's Scientific Encyclopedia, 1968, pp. 214-215.
Merck Manual, 14th ed., (Rahway, N.J.: Merck & Co., Inc., 1982).
Campbell et al.--Chem. Abst., vol. 46, (1952), p. 6797a.
Ricketts--Chem. Abst., vol. 46, (1952), p. 1215f.
Kaplan et al.--Chem. Abst. vol. 83, (1975), p. 53540w.
Vinograd-Finkel et al.--Chem. Abst. vol. 77, (1972), p. 86318j.
Chem. Abst.--8th Coll. Index, Benzimidazolin-By, pp. 5070, 5071, 5144 and 5145, (1972), and 5145s, 5146s and 5076s.
Veis et al., "Phase Separation in Polyelectrolyte Systems, I. Complex Coacervates of Gelatin", Journal of Physical Chemistry, vol. 64, (1960).
Ecanow Bernard
Ecanow Charles S.
Neomed Inc.
Rosen Sam
LandOfFree
Synthetic whole blood substitute and a method of making the same does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthetic whole blood substitute and a method of making the same, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthetic whole blood substitute and a method of making the same will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-58943